Atlanta-based CardioMEMS Inc., developer of an implantable wireless device that helps physicians monitor blood pressure in heart patients, may be breathing a little easier following a federal panel’s ...

PHILADELPHIA -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000, and many patients are in the hospital again and again. But a tiny device is ...

PHILADELPHIA (WPVI) -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000 and many patients are in the hospital again and again. But a tiny device is ...

Atlanta, Georgia-based health device maker CardioMEMS received FDA clearance for its CardioMEMS HF System, which monitors pulmonary artery pressure, but for patients who have experienced New York ...

In a bid to fortify its Heart Failure business, AbbottABT recently announced the start of the - GUIDE-HF clinical trial - largest heart failure medical device study in the United States. The trial ...

As Abbott seeks an expanded indication for its CardioMEMS device for patients with heart failure, it’s also hoping to win over a national coverage decision from the Centers for Medicare and Medicaid ...

CLEVELAND, Ohio (WOIO) -The CardioMEMS device is permanently implanted in patients and provides doctors and nurse practitioners with daily reports. Leading indicators and stats alert the patient and ...

Mark Carlson, St. Jude Medical’s chief medical officer, explains how the CardioMEMS HF System might evolve and shares his vision for the future of epidemic disease care. Heart failure patients used to ...

St. Jude Medical, a medical device company and part owner of Atlanta-based CardioMEMS, plans to exercise an option to acquire all of the company now that CardioMEMS’ heart-failure monitoring device ...

(RTTNews) - Abbott (ABT) reported results of the GUIDE-HF clinical trial which assessed the benefits of the CardioMEMS HF System in an expanded patient population not currently approved for the device ...